Acquired somatic mutations of the PIG-A gene lead to deficient expression o
f glycosyl-phosphatidyl-inositol-anchored proteins (GPI-AP) by haematopoiet
ic cells and play a causative role in the pathogenesis of paroxysmal noctur
nal haemoglobinuria (PNH). However, PIG-A mutations do not explain how the
defective PNH clone can expand. It was hypothesized that a selection proces
s conferring a relative advantage to the GPI-AP-deficient population is req
uired. Since GPI-AP-deficient cells are also detectable in a substantial pr
oportion of patients with otherwise typical aplastic anaemia (AA), the mech
anisms inducing bone marrow failure might selectively spare the GPI-deficie
nt cells. In order to examine the growth characteristics of GPI-AP-deficien
t cells in more detail, we performed repeated analyses of GPI-AP expression
on peripheral blood cells in 41 patients with AA. We observed four pattern
s of the course of GPI-AP-deficient populations: (1) 13 patients showed nor
mal expression of GPI-AP in the first analysis and in at least two follow-u
p studies at a median time of 709 days after the first analysis. (2) Second
ary evolution of a GPI-AP-deficient population was a rare event, Only 4 pat
ients with initially normal GPI-AP expression developed a GPI-AP-deficient
population during follow up after immunosuppressive treatment. (3) Persiste
nce of GPI-AP-deficient cells was observed in 16 patients during a median f
ollow-up time of 774 days. However, in some patients, the size of the GPI-A
P-deficient population increased substantially. (4) Disappearance of a GPI-
AP-deficient population was observed in 8 patients. The time course of GPI-
AP expression in relation to the treatment suggests that therapeutic interv
entions might modulate the ratio of normal versus GPI-AP-deficient haematop
oiesis. Overall, these data argue against an 'absolute growth advantage' of
GPI-AP-deficient cells. Our data are consistent with the hypothesis that h
aematopoietic failure caused by damage to normal haematopoiesis allows the
outgrowth of a GPI-AP-deficient population. Thus, in at least some patients
GPI-AP-deficient cells might pre-exist at a very low percentage and replac
e haematopoiesis after an insult to the normal cells. Copyright (C) 2000 S.
Karger AG. Basel.